Biodesix’ team of scientists in Research and Development utilize an array of technologies to develop clinically validated proteomics and genomics blood- based assays. Our goal is to help our partners rapidly pilot, develop and commercialize clinically relevant tests, including companion diagnostics.

The combination of reproducible high-throughput protein expression measurements with proprietary advanced machine learning algorithms allows us to take advantage of the correlations between protein expression and clinically relevant data to build molecular tests which can be validated and commercialized using the same development platform. VeriStrat®, our serum proteomic test, is one example of our capabilities to discover and develop a robust diagnostic test with clinical utility.